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Edited by J Van StadenThe crude methanol extract of Rosa canina (RC) fruit was tested against multidrug-resistant (MDR) bacterial
strains, including methicillin-resistant Staphylococcus aureus SA1199B, EMRSA16 and XU212 harbouring NorA,
PBP2a and TetK resistance mechanisms, respectively, as well as S. aureus ATCC25923, a standard antimicrobial
susceptible laboratory strain. The inhibition of the conjugal transfer of plasmid PKM101 and TP114 by the RC
extract was also evaluated. The RC extract demonstrated a mild to poor antibacterial activity against the panel
of bacteria having MIC values ranging from 256 to N512 μg/mL but strongly potentiated tetracycline activity
(64-fold) against XU212, a tetracycline-effluxing and resistant strain. Furthermore, the extract showedmoderate
capacity to inhibit the conjugal transfer of TP114 and PKM101; transfer frequencies were between 40% and 45%.
Cytotoxicity analysis of the RC extract against HepG2 cells line showed the IC50 N 500 mg/L and, thus, was
considered non-toxic towards human cells. Phytochemical characterisation of the extracts was performed by
the assessment of total phenolic content (RC: 60.86 mg TAE/g) and HPLC fingerprints with five main peaks at
360 nm. The results from this study provide newmechanistic evidence justifying, at least in part, the traditional
use of this extract. However, the inhibition of bacterial plasmid conjugation opens the possibility of combination
therapies to overcome antibiotic resistance.
© 2016 SAAB. Published by Elsevier B.V. All rights reserved.Keywords:
Rosa canina
Resistance modulator
Anti-plasmid
MDR bacteria
Cytotoxicity1. Introduction
The rapid spread of multidrug-resistant (MDR) bacteria has posed a
serious global health threat over the last decades and continues to con-
stitute a major problem in the treatment of hospital- and community-
acquired infections (Annan et al., 2009). As a consequence, treatment
of infections caused by MDR bacteria strains is becoming increasingly
difficult to manage with existing antibiotics. This is in part due to the
ability of bacteria to evolve mechanisms that thwart antimicrobial
action (Martinez, 2012). Examples include strains of Staphylococcus
aureus such as SA1199B (NorA), XU212 (TetK and PBP2a), RN4220
(MsrA), EMRSA15 and EMRSA16 (PBP2a) that are prominent for their
high level of resistance to antibiotics due to their encoded efflux mech-
anism (Richardson and Reith, 1993; Cox et al., 1995). Recent studies
have suggested the horizontal transmission of genes as a major part of
the growing problem of antibiotic resistance (Dantas and Sommer,
2014). The dissemination of extended-spectrum beta-lactamase
(ESBL) genes, conferring resistance to third-generation cephalosporin
and other β-lactams, are promoted bacteria such as Escherichia coli,
Klebsiella pneumoniae and Acinetobacter spp. (Paterson and Bonomo,
2005). These plasmid-mediated multidrug resistance phenotypes are44 207 7535909.
hts reserved.responsible for compromised treatment of infectious human diseases
(Kumar et al., 2013). Unfortunately, synthetic plasmid-curing agents
such as acridine orange, ethidium bromide and sodium dodecyl sulfate
are unsuitable for therapeutic application owing to their toxic nature.
There is therefore a need to develop new antibiotics with alternative
mechanisms to overcome bacterial resistance, as resistance-modifying
and efflux inhibitors or plasmid-curing compounds (Spengler et al.,
2006; Stavri et al., 2007). In this context, plant-derived products have
been proposed as potential candidates of drugs leads to combat bacteri-
al resistance mechanisms (Hollander et al., 1998) through the reversal
of MDR phenotypes facilitating the re-establishment of use of existing
antibiotics.
Rosa canina L (Rosaceae; RC) known as rose hip or dog rose ismostly
used traditionally as a dietary supplement and a herbal remedy for the
prevention and treatment of diverse human diseases such as diabetes,
kidney disorders, inflammation, ulcer and cancer, but only a few of
these have any in vitro scientific data to support these indications
(Chrubasik et al., 2008). In the traditional medicine, 2–5 g of the
R. canina fruits is prepared and used internally as tea (a cup taken 3 to
4 times per day) to strengthening the body immune system against in-
fections such as common colds, influenza, scurvy, diarrhoea, gastritis,
cough, vaginitis and urinary tract infections (Sen and Gunes, 1996).
The strong antimicrobial potential of R. canina against certain micro-
organisms has been documented (Horvath et al., 2012). The extracts
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acid, tocopherol, tannins, pectin, minerals, fatty acids, carotenoids and
phenolic compounds (Chevallier, 1996; Ozturk and Sezai, 2011). It has
previously been reported that tellimagrandin I isolated fromRC reduced
the MIC of oxacillin and tetracycline against four MRSA strains (Shiota
et al., 2000). Presently, there is no scientific data on the antibacterial
properties of RC fruits against strains with characterised efflux-
mediated mechanisms of resistance or the capacity to inhibit plasmid
transfer. This study therefore aimed to investigate the antibacterial;
plasmid conjugation inhibition and antibiotic modulation potential of
the methanol extract of R. canina fruit against selected MDR S. aureus
strains. In addition, their differential cytotoxicity against mammal cells
expressing efflux pumpswas also determined using the sulforhodamine
B (SRB) assay with human liver carcinoma cells (HepG2).2. Materials and methods
2.1. Plant extracts collection and preparation
R. canina L (RC) fruits were obtained in fully dried and powdered
form from Herbs in a Bottle Ltd. UK, and a voucher specimen (No. RC-
001)was deposited at the herbarium in the School of Pharmacy, Univer-
sity College London (UCL). Fifty grams of the dried powdered materials
was extracted in 300 mL of methanol, at room temperature by constant
mechanised agitation in an ultrasonic bath, for 45 min. The extract was
filtered using a Buchner funnel andWhatmanNo. 1filter paper. The vol-
umewas concentrated under vacuum at 40 °C to recover the methanol,
air-dried, weighed and stored in a refrigerator at 6 °C for future use.2.2. Bacterial strains
The antibacterial assay was performed against strains of Staphylo-
coccus aureus: SA1199B and XU212 areMDR strains that overexpress
the NorA and TetK efflux transporter proteins with a high level of re-
sistance to norfloxacin and tetracycline, respectively. EMRSA15 and
EMRSA16 are the major epidemic methicillin-resistant S. aureus
strains in UK hospitals site (Richardson and Reith, 1993; Cox et al.,
1995). S. aureus ATCC25923, E. coli NCTC 10418 and Pseudomonas
aeruginosa NCTC10662 are standard susceptibility testing control
strains. S. aureus RN4220 is a macrolide-resistant strain, while
K. pneumoniae 342 and Proteus spp. P10830 are MDR clinical isolates.
The plasmid conjugal inhibitory potential of RC extract was tested on a
conjugal transfer system of E. coli bearing the TP114 plasmid, which en-
codes for kanamycin resistance and E. coli harbouring the PKM 101,
which codes for ampicillin resistance. The recipient did not harbour
plasmids but had chromosomally encoded resistance to streptomycin.
All the bacteria and plasmids tested were obtained from Dr. Paul
Stapleton of the Research Department of Pharmaceutical and Biological
Chemistry, School of Pharmacy, University College London (UCL).2.3. Cell culture and maintenance
The HepG2 cell lines (American Type Culture Collection) were ob-
tained fromProf. Andreas Kortenkamp formerly at the ResearchDepart-
ment of Pharmaceutical and Biological Chemistry, School of Pharmacy,
University College London (UCL). HepG2 cells were replenished with
new growth medium every 2–3 days and sub-cultured every 3–4 days
when they were 80% confluent. Cells were maintained in DMEM
(Invitrogen, UK) containing 10% foetal bovine serum (GIBCO 10010)
and antibiotics [penicillin (100 IU/mL) and streptomycin (100 mg/L)],
incubated at 37 °C in a 5% CO2 humidified atmosphere and split when
confluent. The cell density was adjusted to 7.5 × 104 cells/mL before
exposure to different concentrations of plant extracts prepared in
1% w/v DMSO.2.4. Total phenolic content (TPC)
The total phenolic content of the methanol extract from RC was
determined with Folin–Ciocalteu reagent using the method of
Lister and Wilson (2001) with slight modification. A volume of
0.5 mL of the plant extract (1000 mg/L) was added to 2.5 mL of
10% v/v Folin–Ciocalteu reagent (FCR) and 2 mL of 20,000 mg/L
Na2CO3. The resulting mixture was incubated at 45 °C with shaking
for 15 min, followed by measuring the absorbance at 765 nm. The
calibration curve of the standard tannic acid (1 mL; 25–400 mg/L)
was prepared following the same method. The experiment was con-
ducted in triplicate, and the results were reported as mean ± SD
values. Tannic acid equivalents (TAE) in the plant extract was calcu-
lated by the following formula: T = CV/M, where T is the TPC (mg/g)
of the extract in TAE, C is the concentration of tannic acid established
from the calibration curve, V is the volume of the extract (mL) andM
is the weight of the extract (g).
2.5. Minimum inhibitory concentration (MIC) assay
The minimum inhibitory concentrations (MICs) of the antibiotics
and plant extract were determined against resistant bacteria using the
method described by Shiu and Gibbons (2006). The bacterial strains
and isolates were grown at 37 °C overnight on nutrient agar and inocula
of the test organisms were prepared in normal saline (9 g/L) and
compared with a 0.5 McFarland standard and diluted to achieve
5 × 105 CFU/mL. A volume of 100 μL of Mueller Hinton broth (MHB)
was dispensed into 96 wells of microtitre plate. A stock solution of
antibiotics or drug extracts was prepared in dimethyl sulfoxide
(DMSO) (Sigma) and further diluted in MHB (1.5 mL) to reduce
DMSO concentration to 1%. One hundred microliters of stock solu-
tion of 2048 mg/L was dispensed into the first well and serially dilut-
ed into each well, added with 100 μL of standardised bacterial
inoculum to give a final concentration that ranged between 512
and 1 mg/L for the extract and 128 to 0.03 mg/L for the antibiotics.
All procedures were performed in duplicate; the plates were incu-
bated at 37 °C for 18 h. A volume of 20 μL of a 5 g/L methanol solution
of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT; Sigma) was added to each well and incubated for 30 min. A
blue coloration indicated bacterial growthwhile theMIC was record-
ed as the lowest concentration at which no visible growth was
observed.
2.6. Bacterial resistance modulation assay
For the evaluation of extracts as antibiotic resistance modulators,
MICs of norfloxacin and tetracycline were determined in the presence
or absence of sub-inhibitory concentrations (SIC) of the extract (64–
512 mg/L) against susceptibility testing control strain S. aureus ATCC
25693 and three resistant S. aureus isolates: XU212, SA1199B and
EMRSA16 following the procedure described by Oluwatuyi et al.
(2004) with slight modification. A volume of 100 μL of MHB was dis-
pensed in each well except wells in column 1 that contained 100 μL of
the extract. The samples at the stock concentrations (256–2048 mg/L)
were chosen to obtain one-quarter MICs and were introduced into
wells 2–10, while 100 μL of the appropriate antibiotic (MICs) was
added into well 1 and serially diluted across the plate leaving well 11
empty for final growth control and well 12 as sterility controls. To the
wells in rows four to six, 100 μL of 20 mg/L reserpine (a modulatory
agent) was added. All strains were cultured on nutrient agar slope
before MIC determination. Overnight cultures of each strain were
prepared in 9 g/L saline to an inoculums density of 5 × 105 CFU/mL. To
the wells, 100 μL of a standardised inoculum was added, but wells in
rows seven and eight were maintained free from the extracts and
reserpine. All experiments were performed in triplicate under aseptic
conditions. The MIC was determined as mentioned above.
Table 1
Antibacterial activities of methanol crude extracts from Rosa canina fruits against MRSA
and MDR bacterial strains.
MIC of plant extracts/antimicrobial agents (mg/L)
Bacteria RC CIPR Tet Norx Ery
Proteus mirabilis (P10830) 512 32
Klebsiella pneumoniae (342) N512 ≤0.03
Pseudomonas aeruginosa (10,662) 256 ≤0.03
Escherichia coli (NCTC 10418) N512 ≤0.06
¶EMRSA15 256 0.25
¶EMRSA16 512 0.25
¶XU212 N512 16
¶SA1199B N512 32
*ATCC25923 N512 0.5
¶RN4220 N512 32
Norx stands for norfloxacin; Tet: tetracycline; CIPR; ciprofloxacin; and Ery: erythromycin,
which was used as control. Bacteria culture without drug treatment was used as negative
control. RC: Rosa canina.¶ denotes bacteria with efflux protein transporter, SA1199B
possesses the NorA efflux transport protein, RN4220 (MsrA) XU212 (TetK), EMRSA15
and 16 (mecA) and ⃰ ATCC25923 a standard laboratory strain.
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The plasmid conjugal transfer inhibition assaywas performed by the
brothmatingmethod described by Rice and Bonomo (2007) with some
modifications. Mating between the plasmid-containing donors strains
E. coli K12J53 and the recipients E. coli ER1793 and JM 109 were per-
formed in Luria–Bertani (LB) broth. The independent overnight cultures
of the plasmidswere inoculated into 5mLof fresh LB broth and incubat-
ed overnight with shaking at 37 °C. Donor and recipient cultures were
mixed 1:1 in 100 μL of LB with 100 mg/L of each of the extracts or
10mg/L of standard novobiocin to a final volume of 200 μL and incubat-
ed overnight at 37 °C. For time course experiments, overnight cultures
were mixed and mated in the presence of the drug or without drug
(negative control) and incubated for the time periods stated. Only the
bacteria that had successfully taken up the resistance gene and become
resistant grew indicating plasmid conjugation.
2.8. Sulforhodamine B (SRB) assay
Themethod described byHoughton et al. (2007)was adopted to test
for the toxicity of the plant extract using the HepG2 cell line. A volume
of 100 μL cell suspension of optimum density was introduced into each
well of a 96-well plate. Plant extract concentrations that ranged be-
tween 15.625 and 500 μg/mL were prepared in the culture medium,
and 100 μL of each extract concentrationwas added to the cellmonolay-
er and control well. The range of the concentrations was chosen to de-
termine if the plant extract within this concentration could raise
concern in the treatment of chronic diseases and if it is responsible for
the MIC values against the tested bacterial strains. Monolayer cells
were incubated with the drug extracts or standard doxorubicin (posi-
tive control) or without treatment (negative control) for 48 h, and
cells were fixed with ice-cold TCA for 1 h at 4 °C. After incubation, the
plates were washed five times in sterilised distilled water and then
air-dried. A volume of 50 μL of sulforhodamine B (0.4%w/v in 1%v/v
acetic acid) solution was added to each well of the dry 96-well plates
and allowed to stain at room temperature for 30min. The SRB unbound
dye solution was removed after staining by washing the plates five
times with 1% v/v acetic acid. The bound SRB dye was solubilised by
adding 100 μL of 10 mM non-buffered Tris base (pH 10.5) to each
well, shaking for 5 min. The plates were read in a 96-well plate reader
at 492 nm. The mean background absorbance was subtracted, and the
mean values of each drug concentration were calculated. The IC50
value of tested extract was then calculated.
2.9. HPLC/DAD analysis for phenolic compounds
The phenolic compounds in the fruit methanol extracts from RC
were identified and characterised by HPLC-DAD according to the
method described by Giner et al. (1993). All analyses were performed
using a Hewlett-Packard Chemstation series 1100 chromatograph
(Agilent, Palo Alto, CA, USA), coupled with a diode array detector. Ten
milligrammes of the plant samples were sonicated in HPLC grademeth-
anol (1 mL) for 30 min. The resultant mixtures were centrifuged at
10,000g for 10 min and the supernatants were used for the HPLC/DAD
analysis. The resulting solutions were filtered through a 0.22 μm filter
and 10 μL aliquots of the filtrates were injected onto the HPLC system.
This system comprised a RP Nova Pack C18 column (300 × 3.9 mm)
packedwith 4 μmparticles and a pre-column containing the samepack-
ing material. The columns were eluted in two solvent systems: Solvent
A (water/phosphoric acid, 0.1%) and solvent B (methanol). The solvent
gradient was composed of A (75–0%) and B (25–100%) for 20 min,
then 100% B for 4 min, then again at the initial conditions (75% A and
25% B) for 10 min. A flow rate of 1.0 mL/min was used at 30 °C. The
UV spectral data for all peaks of different compoundswere accumulated
in 285 nm and recorded using DAD. These compounds were identifiedby comparison of their retention times and spectra of each peak with
those of known standards analysed in the same conditions.
2.10. Statistics
Data analysis was done with Microsoft Excel to obtain descriptive
statistics. Means were separated by the Duncan multiple test using
SAS. The different levels of significance within the separated groups
were analysed using one way analysis of variance (ANOVA). Values
were considered significant at P b 0.05.
3. Results and discussion
3.1. Total phenolic content (TPC)
The TPC of the RC extract was expressed as tannic acid equivalents
(TAE). The TPC valuewas found to be 60.86± 0.04mg TAE/g for RC, ex-
trapolated from the standard tannic acid curve: Y = 0.1216×; R2 =
0.93651. The data recorded for RC fruits was contrary to that of
Montazeri et al. (2011) who reported 424.6 ± 1.8 mg/gallic acid equiv-
alent (GAE)/g but corroborated with the findings (59.69 ± 0.89 mg
GAE/g dry matter) of IIbay et al. (2013). The observed inconsistency
could be attributed to different climatic conditions, the standard equiv-
alent used, solvent system and/or processing methods. Moreover,
the Folin–Ciocalteu reagent (FCR) has been used to measure other
compounds and hence may not give a concise amount of the phenolic
compounds present. However, a HPLC/DAD chromatogramwith detec-
tion at 360 nm showed the presence of five major peaks of phenolic
compounds for the RC extract between a retention time of 2 and 25min.
3.2. Antibacterial activity of RC extract
The methanol extract showed a mild to poor antibacterial activity
with minimum inhibitory concentration (MIC) values ranging between
256 and N512 mg/L, whereas the standard antibiotics used as controls
ranged from ≤0.03 to 0.5 mg/L as summarised in Table 1. According
to Rios and Recio (2005), extracts can be classified as significant
(MIC b100 mg/L), moderate (100 b MIC = 512 mg/L) or weak
(MIC N 512 mg/L) depending on their respective activities against the
corresponding pathogens. The same criterion was used elsewhere to
classify the antimicrobial activities of plant extracts (Kuete et al.,
2011; Fouotsa et al., 2013). This scheme was further supported by
Gibbons (2008) and Van Vuuren (2008) who considered crude extracts
withMICs greater than 512mg/L, being poorly active and isolated com-
pounds withMIC less than 10mg/L as being interest to Pharma for drug
formulation. Utilising this scheme, the RC extract demonstrated a
Fig. 1. Percentage (%) plasmid transfer frequency of PKM 101 and TP114 in the presence
and absence of Rosa canina extracts (100 mg/L). **P b 0.05 compared to novobiocin
(10 mg/L) treatment. Novobiocin was used as positive control while plasmid culture
without drug treatment was used as negative control.
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(Richardson and Reith, 1993; Cox et al., 1995), the major epidemic
methicillin-resistant S. aureus strains occurring in UK hospital, as well
as Proteus spp. P10830 and P. aeruginosa 10,662withMIC values ranging
between 256 and 512 mg/L, but was less active towards other MDR or-
ganisms (MIC N 512 mg/L). The poor antibacterial activity of RC fruit is
consistent with the report of Yilmaz and Ercisli (2011) against certain
bacteria. Although the MIC values obtained from extracts against the
test organismsweremuchhigher compared to the antimicrobial agents,
this is likely to be due to the complex mixture of the phytochemicals in
the sample.
3.3. Antibiotic resistance-modifying activity
The bacterial resistance-modifying activity of the RC extract in the
presence of either norfloxacin or tetracycline against four bacterial
strains (SA1199B, XU212, ATCC25923 and EMRSA16) is depicted in
Table 2. The combination of RC extract with norfloxacin had no effect
on the activities towards EMRSA16 and ATCC 25923. Interestingly, an
increase in the MIC of norfloxacin was recorded against SA1199B, sug-
gesting antagonism. Moreover, when tested against the tetracycline-
resistant strain (XU212) expressing the TetK efflux transporter, a
sixty-four-fold reduction in the MIC was noted at a sub-inhibitory con-
centration (SIC). When reserpine, a known efflux inhibitor, was com-
bined with norfloxacin or tetracycline, a four-fold potentiation was
observed towards EMRSA16, ATCC25923 and XU212 while eight fold
reductions in the MIC of norfloxacin was displayed against SA1199B.
The development of efflux pump inhibitors has been proposed to be
used in conjunction with existing antibiotics to improve therapeutic ef-
ficacy and suppress the emergence of resistant variants that may arise
during treatment (Gibbons et al., 2003). Although the plant extract
showed promising resistance-modifying properties against XU212 and
appeared to overcome the efflux mechanisms present, the isolation of
their active principles could provide useful drug leads to reverse
antibiotic resistance mechanisms in clinically relevant pathogens.
3.4. Plasmid conjugal inhibition activity
The search for inhibitors of plasmid-mediated resistance is currently
gaining new ground, with only a small number of synthetic compounds
that are identified (Hooper, 2005) but are unsuitable for clinical applica-
tion due to their neurotoxicity. Consequently, recent studies have con-
centrated on natural products in order to identify natural inhibitors of
bacterial conjugation (Lakshmi et al., 1987). Here, the ability of RC ex-
tract to reduce the transfer frequency of the plasmids TP114 and PKM
101 was evaluated. TP114 is a self-transmissible plasmid belonging to
Incl2 compatibility group. It is isolated from E. coli (Carattolia and
Bertinia, 2005) that encodes a kanamycin resistance determinant.
PKM 101 belongs to the IncN compatibility group, which is a variant
of the parent plasmid R46 (Langer and Walker, 1981), and confers
ampicillin resistance via β-lactamase production. Moderate inhibitory
activity against the transfer of TP114 and PKM101 was demonstratedTable 2
Minimal inhibitory concentrations (mg/L) of selected antimicrobial agents in the presence
and absence of plant extracts (MIC/4) and reserpine (20 mg/L).
Treatment EMRSA16
(mecA)
SA1199B
(norA)
ATCC25923 XU212
(TetK)
Norfloxacin 128 32 0.5 –
Tetracycline – – – 128
RC + Norfloxacin 128 (0)a 64 0.5 (0)a –
Reserpine + Norfloxacin 128 (4)a 4 (8)a 0.125 (4)a –
RC + Tetracycline – – – 2 (64)a
Reserpine + Tetracycline – – – 32 (4)a
RC, Rosa canina; Reserpine + Tetracycline; and Reserpine + Norfloxacin were used as
positive controls.
a Potentiation values.by RC despite a weak antibacterial and resistance-modifying effect,
signifying a different mechanism (Fig. 1). R. canina is notable for its
phenolic constituents and this class of compound are typified by
bharangin isolated from Pygmacopremna herbacea (Roxb), together
with gossypetin and gossypin, known to cause the loss of the TP181
plasmid as well as a penicillinase-conferring plasmid in E. coli 46R41
(Skehan et al., 1990). Novobiocin was used as the reference control at
10 mg/L, having 81.7% and 83% plasmid conjugal transfer frequency
for PKM 101 and TP114, respectively. Synergy in whole plant medicines
or crude extract treatments is very commonly responsible in bioactive
extracts, especially given that many folklore medicines are co-
administered with one or more preparations (Hollander et al., 1998).
In RC, the combinatorial effect of the crude extract may possibly facili-
tate transport across the bacterial cell wall, which could aid maximum
absorption of the drug to assist the inhibition of the conjugation process.
However, further bioassay-guided isolation of the active crude extract is
recommended to identify individual compounds.
3.5. SRB cytotoxicity potential of the extracts
Numerous assays such as MTT (3-(4, 5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide), XTT (2,3-bis(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide sodium salt) and SRB
(sulforhodamine B) have been employed to evaluate toxic effects of
chemicals on the membrane integrity, mitochondrial function or pro-
tein synthesis in mammalian cells (Fricker and Buckley, 1996). TheFig. 2. Sulforhodamine B viability assay of HepG2 cells treated with methanol extracts
from Rosa canina (RC) fruits. Confluent cultures were treated for 48 h prior to SRB assay.
Data are expressed as % of control ± SD (n = 6). Doxorubicin (0.5 mg/L) was used as
postive control and HepG2 cells with 1% DMSO was used as negative control.
Fig. 3. HPLC-DAD chromatograms of standard phenolic acids (A) commonly found in plants, the peaks correspond to gallic acid (1), gallic acid (2) rutin. (B) The chromatograms of
methanol extracts (1 mg/mL) from powdered Rosa canina fruits at 360 nm.
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the ability to bind to protein basic amino acid residues of trichloroacetic
acid (TCA) fixed cells (Keepers et al., 1991). It is sensitive, simple, repro-
ducible andmore rapid than the formazan-based assays with better lin-
earity without a time-sensitive measurement as regarding the MTT or
XTT assays (Marie-Magdeleine et al., 2010). The effect of the RC
(IC50 N 500 mg/L) extract on HepG2 cell viability was assessed using a
colorimetric assay that evaluates cell number indirectly by staining
total cellular protein with the SRB dye (Marie-Magdeleine et al., 2010)
as presented in Fig. 2. The RC extracts did not impair lysosomes as com-
pared with the standard doxorubicin (0.5 mg/L: 52.45%) a chemothera-
peutic agent used for the treatment of many different cancer types. A
similar observation was reported by Cagle et al. (2012) and thus sup-
ports the safe use of this botanical as complementary and alternative
therapy in the prevention or treatment of certain health problems.
Theweak toxic effect could be linked to its hydrophilic nature inhibiting
the interaction with the cell membranes where signal transduction
pathways occur (Atmani et al., 2011).
3.6. HPLC-DAD analysis for phenolic fingerprints
The chromatogram at 360 nm showed the presence of 5 peaks of
phenolic compounds with retention times (RT) between 4 and
25 min. Due to limited amount of the extract, the HPLC fingerprints
were determined, which showed major peaks at the RTs (min) of
4.75, 7.538, 13.2, 15.334 and 22.874 as shown in Fig. 3. Here, none of
the peaks identified based on their RT and UV/DAD absorption spectra
corresponded with those of the standards (gallic acid and rutin).
However, the peaks at 15.334 and 22.87 were somewhat similar to
methyl gallate and quercetin-3-galactoside, respectively, as reported
by Hvattum (2002). Other compounds identified by the same author
aremissing in this work, conceivably due to the difference inmethodol-
ogy and solvent system used. Further studies would be carried out to
identify and quantify the major peaks of these compounds.
4. Conclusion
We have shown that while the RC extract had mild to poor antibac-
terial activity, the sample was able to potentiate tetracycline activity
against tetracycline-resistant strain XU212 possessing a multidrug ef-
fluxmechanism and had amoderate inhibitory effect on plasmid conju-
gation. Encouragingly, the RC extract did not exhibit any significant
toxic effect to mammalian cells and thus substantiate its safe use as a
complementary and alternative therapy for the treatment or preventionof human diseases. Further research is ongoing to identify active ingre-
dient and themechanism of interaction with antibiotic against resistant
bacterial strains.
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